Aceragen Inc.
Biotechnology
Healthcare
ACGN
3.71 M shares
NASDAQ US
traded
19 Jul 2023
listed
no
open
1.54
52 week high
9.18
high
1.54
52 week low
0.23
low
1.42
growth
0.00 %
previous Close
1.50
P/E ratio
-0
market cap
div yield
0
usd
Mar 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
-2.94 %
0.00 %
eps surprise
0.00 %
net profit margin
0.00 %
223.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top